Difference between revisions of "Team:CGU Taiwan/Results"
JackieLiao (Talk | contribs) |
JackieLiao (Talk | contribs) |
||
| Line 38: | Line 38: | ||
} | } | ||
.mid { | .mid { | ||
| − | |||
margin-left: 250px; | margin-left: 250px; | ||
width: 700px; | width: 700px; | ||
| Line 310: | Line 309: | ||
| − | <div class="mid" style="top: | + | <div class="mid" style="margin-top:150px;background-color:white;"> |
<br><br><br> | <br><br><br> | ||
<div style="font-size:40px;color:#140731;text-decoration:none;top:10px;">Results</div><br> | <div style="font-size:40px;color:#140731;text-decoration:none;top:10px;">Results</div><br> | ||
Revision as of 21:09, 19 October 2016
Leijuvant
Results
Shuttle vector-Leishmania antigen expression system
Leijuvant-the immune response of photo-inactivated leishmania as adjuvant in mice
Prediction-Dendritic cell MHC peptide presentation
Shuttle Vector
Introduction
Design
Result
Leijuvant
Introduction
Design
Result
MHC Presentation
Introduction
Design
Result
